Liberty Square Wealth Partners LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 66.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,211 shares of the company's stock after selling 4,316 shares during the quarter. Liberty Square Wealth Partners LLC's holdings in Procter & Gamble were worth $352,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the business. Balboa Wealth Partners raised its stake in Procter & Gamble by 16.6% in the 2nd quarter. Balboa Wealth Partners now owns 6,431 shares of the company's stock worth $1,025,000 after purchasing an additional 915 shares in the last quarter. West Tower Group LLC acquired a new stake in Procter & Gamble in the 2nd quarter worth about $398,000. Swan Global Investments LLC raised its stake in Procter & Gamble by 33.6% in the 2nd quarter. Swan Global Investments LLC now owns 2,183 shares of the company's stock worth $348,000 after purchasing an additional 549 shares in the last quarter. Calamos Wealth Management LLC raised its stake in Procter & Gamble by 16.9% in the 2nd quarter. Calamos Wealth Management LLC now owns 22,867 shares of the company's stock worth $3,643,000 after purchasing an additional 3,300 shares in the last quarter. Finally, Cidel Asset Management Inc. increased its holdings in Procter & Gamble by 0.7% in the 2nd quarter. Cidel Asset Management Inc. now owns 77,266 shares of the company's stock valued at $12,310,000 after buying an additional 519 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have commented on PG. Berenberg Bank raised their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a report on Wednesday, September 17th. Evercore ISI reissued an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. BNP Paribas Exane decreased their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a report on Tuesday, September 23rd. Wells Fargo & Company decreased their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a report on Thursday, September 25th. Finally, Barclays decreased their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a report on Wednesday, October 1st. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $172.21.
View Our Latest Research Report on PG
Insider Buying and Selling at Procter & Gamble
In related news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider directly owned 12,616 shares in the company, valued at $1,920,533.68. This trade represents a 3.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. This represents a 3.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock worth $23,421,279 over the last quarter. Insiders own 0.20% of the company's stock.
Procter & Gamble Trading Up 1.3%
Shares of Procter & Gamble stock opened at $151.53 on Monday. The firm has a market capitalization of $354.66 billion, a PE ratio of 23.28, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm's 50 day moving average is $154.92 and its 200 day moving average is $158.67. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
